UPDATE: 9/9/2020 - BLVK has submitted our PMTAs via the CTP Portal to the U.S. Food and Drug Administration (FDA) seeking authorization for the marketing and sale of our wide-range of e-liquid products. This is truly another milestone for us as it puts us one step further through the review process in hopes of receiving a marketing order from the FDA. We have always valued transparency, and our PMTA submission will provide the FDA everything t hey need to deem our vapor products appropriate for the protection of public health. We are confident with the thorough product analysis we've submitted, and we're hoping for a positive review by the FDA to continue providing our products to responsible adults seeking alternatives to traditional combustible tobacco products.